Sonoma Pharmaceuticals (SNOA) Capital Expenditures (2010 - 2026)
Sonoma Pharmaceuticals (SNOA) posted quarterly Capital Expenditures of $29000.0 for Q1 2026, down 38.3% year-over-year from $47000.0 in Q1 2025, and down 38.3% quarter-over-quarter from $47000.0 in Q4 2025.
Sonoma Pharmaceuticals (SNOA) Capital Expenditures (2010 - 2026) Analysis & Trends
Sonoma Pharmaceuticals' Capital Expenditures history runs 17 years deep, the most recent figure standing at $29000.0 for Q1 2026.
- In Q1 2026, Capital Expenditures fell 38.3% year-over-year to $29000.0; the TTM figure through Mar 2026 stood at $192000.0 (up 140.0% YoY), while the FY2026 annual figure was $192000.0, up 140.0% from the prior year.
- Capital Expenditures for Q1 2026 stood at $29000.0, down from $47000.0 in the prior quarter.
- The five-year high for Capital Expenditures was $190000.0 in Q1 2023, with the low at -$18000.0 in Q1 2024.
- The 5-year median for Capital Expenditures is $25000.0 (2022), against an average of $35588.2.
- The sharpest annual moves came in 2022 and 2024: Capital Expenditures jumped 3000.0% in 2022, then slumped 109.47% in 2024.
- Sonoma Pharmaceuticals' Capital Expenditures stood at $31000.0 in 2022, then plunged by 96.77% to $1000.0 in 2023, then surged by 100.0% to $2000.0 in 2024, then surged by 2250.0% to $47000.0 in 2025, then slumped by 38.3% to $29000.0 in 2026.
- Business Quant data shows SNOA's Capital Expenditures at $29000.0 in Q1 2026, $47000.0 in Q4 2025, and $10000.0 in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Capex (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 43.83 Bn | 42.86 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 42.87 Bn | 39.22 Bn | 2.15 Bn | 104.00 Mn |
| 3 | Zoetis | 31.41 Bn | 29.73 Bn | 1.05 Bn | 117.00 Mn |
| 4 | Takeda Pharmaceutical | 28.55 Bn | 22.75 Bn | 5.10 Bn | -337.60 Mn |
| 5 | United Therapeutics | 22.08 Bn | 19.42 Bn | 683.80 Mn | 108.00 Mn |
| 6 | Viatris | 18.73 Bn | 17.84 Bn | 1.46 Bn | 52.80 Mn |
| 7 | Neurocrine Biosciences | 15.44 Bn | 15.05 Bn | 935.80 Mn | 7.80 Mn |
| 8 | Elanco Animal Health | 11.75 Bn | 11.22 Bn | 798.00 Mn | 33.00 Mn |
| 9 | Dr Reddys Laboratories | 10.11 Bn | 9.94 Bn | - | - |
| 10 | Sonoma Pharmaceuticals | 5.17 Mn | -165,129.89 | 2.58 Mn | 2,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 2,000.00 |
| Jun 30, 2026 | 2,000.00 |
| Mar 31, 2026 | 29,000.00 |
| Mar 31, 2026 | 29,000.00 |
| Dec 31, 2025 | 47,000.00 |
| Dec 31, 2025 | 47,000.00 |
| Sep 30, 2025 | 10,000.00 |
| Sep 30, 2025 | 10,000.00 |
| Jun 30, 2025 | 106,000.00 |
| Jun 30, 2025 | 106,000.00 |
| Mar 31, 2025 | 47,000.00 |
| Mar 31, 2025 | 47,000.00 |
| Dec 31, 2024 | 2,000.00 |
| Dec 31, 2024 | 2,000.00 |
| Sep 30, 2024 | 26,000.00 |
| Sep 30, 2024 | 26,000.00 |
| Jun 30, 2024 | 5,000.00 |
| Jun 30, 2024 | 5,000.00 |
| Mar 31, 2024 | -18,000.00 |
| Mar 31, 2024 | -18,000.00 |